Get started

Health

+2068% : How the Coronavirus impact this companyHello everyone. Today I will not give a technical analysis, but I just want to show you how the coronavirus can impact the market. This company, China Health Group , has recently discover that the Ritonavir has Inhibitory effect on the new coronavirus. What is Ritonavir ? Ritonavir, sold under the trade name Norvir, is an antiretroviral medication used along with other medications to treat HIV/AIDS. This combination treatment is known as highly active antiretroviral therapy (HAART). Often a low dose is used with other protease inhibitors. It may also be used in combination with other medications for hepatitis C. Also, they are the only producer of Ritonavir in China. Ritonavir Immediately after the news was spread, this company take, in 2 days, more than 2000% . I really think that a lot of company related to the health sector, such as this one, can surge very fast. Better than a lot of shitcoin !
HKEX:8225
by GoldenNaim
1
Mediclinic - Looking for healthy gains.Buy Mediclinic (MDC.L) Mediclinic International plc (Mediclinic) is an international private healthcare services provider. Mediclinic is focused on providing acute-care, specialist-orientated, multi-disciplinary healthcare services. M arket Cap: £2.7Billion Mediclinic broke above resistance at 374p back on the 17th October 2019. The momentum did not continue as the shares have consolidated lower in recent days. The move higher today is an impressive once and this appears to have completed a bullish flag/pennant pattern. This is often considered a continuation pattern and therefore further upside is expected from here. Stop: 351.5p Target 1: 458p Target 2: 500p Target 3: 512p Interested in UK Stocks? Join our free Telegram channel for up to date analysis on the best main market opportunities in the UK right now - t.me
MLong
by Investamate
100% Buy Signal on CRSPThe Megalodon indicators are giving us a buy signal on CRSP Therapeutics! The backtesting results are 100% on this stock so don't miss out on these profits! The Megalodon indicator uses a machine learning algorithm, combined with data from over 500 buy setups, and over 2000 indicators to produce extremely accurate buy signals on any and all asset classes! You will also receive real time buy and sell signals for the stock market, cryptocurrency, as well as forex markets! We also busy completed our cryptocurrency automated trade bot. It trades for you, using our backtested indicator with phenomenal results! So try it today!!!
NASDAQ:CRSPLong
by RandallGurule
1
Bullish Trajectory for AMRS - ReportAMRS has been on a downward spiral for the last couple of years, but within recent time thcompany is pledging towards creating an effective approach towards future advancements. While also presenting at the paradigm capital biosynthesis conference on April 15th in Toronto. (Source Yahoo Finance) Not investment advice. For personal and educational purposes only. (I am attempting to utilize a less indicator approach and more so price action). Any tips would be greatly aappraciated. Thank you
ALong
by LionGate
WHERE WILL BTC STOP ITS UPTREND?Btc can stop trending at any time. Price actually hitting the resistance highlighted in the chart isn't a guaranteed thing, though it will act as a significant pivot. Most likely price will be rejected off of the 1.25 standard deviation of the longest over expanded period (which at this time is the 530 period.) If price DOES go over that pivot, price will revert fully to the 530 moving average with very high probability. The indicator shown is 3D WAVE PM. It is designed to display 128 separate periods of distributional width (how wide the standard deviations on a bellcurve are relative to each other,) and represented as a. heatmap. With this reading, you can find the most significant pivots for sustainable growth to identify the two major market conditions, "trending" and "not trending." Want to learn more about trading with mass as a metric? Find more resources below.
BITFINEX:BTCUSDLong
by DadShark
($BHC )Bausch health (VRX) jammed triangle Simple update today for ex-Valeant (VRX) now Bausch Health. We have a a triangle with squeezed volatility. Positions can me taken once the edges will be broken. As for now we are really closed to the lower line at 22,26 dollars. At the moment watch and wait would be the most logic solution. Aggresive traders can take long position with SL lower than 22, 26, but it might be somewhat risky (because secondary main trand is bearish). RSI is quite down but at the moment there are no divergences suggesting a trend inversion (bullish).
NYSE:BHC
by TRADOMICS_
PTOY LONG HODL Get it while it's hot!This company is going places, I have been researching the team, the fundamentals, and TA for about a week or two for a few hours every day. The entirety of the staff checks out and they have built a HIPPA approved platform to interface with EMR companies. This will revolutionize healthcare as we know it, they have a free app coming out this month for patients to interface with their care team as well as other individuals with similar conditions. They have been chosen to present at a convention in Atlanta October 2017, have been picked multiple times in multiple places one of the top ten most influential companies, not even at events solely restricted to the crypto space...top ten out of hundreds of other companies. This will disrupt healthcare IT as we know it! They are also doing a trial at 8 hospitals for ninety days. This will climb throughout that time and if even one of those 8 hospitals signs on after the 90 day trial that will send it flying. I have connections in the healthcare space, (specifically pharmaceuticals and EMR) and I have showed them this company and their plan of action and they agree that it is a winner. Oh did I mention they are HIPPA compliant, yes I did, but that is HUGE. My understanding is that they can interface with current EMR companies as well as having the technology to possibly replace them down the road. My understanding is they are also aligned with Kaiser Permanente which is almost enough right there. If you have a little more time than I have taken already there is a great analysis on medium that I cannot take credit for. medium.com Writing this I feel like a schill but this is far from the truth, I have bought in 3x and plan to as much more as I can, my family is and my friends are. This one is a win that I may not ever let go of.
PLong
by Uptrender2ThePhlow
3
$IDXG On a Clear Breakout with Potential News Down Pipeline$IDXG Latest Insider Purchases, Institutional Ownerships and News: 2016-02-03 Glorikian Harry Director Acquired 127,696 2016-02-03 KEEGAN JOSEPH D Director Acquired 127,696 2016-02-03 STOVER JACK E Interim President and CEO Director Acquired 294,756 2016-02-03 SULLIVAN STEPHEN J Director Acquired 295,656 2017-06-23 SC 13G ARMISTICE CAPITAL, LLC Acquired 965,784 John P. Dugan (Founder): 4,869,878 common shares Other Insiders Approximately: 2,672,149 shares collectively Total Insiders: 7,542,027 shares Institutional Ownership: 30.6% 5.5 mil shares (Increased to 6.5 mil as of June 23rd) Largest Institutional Holder: Heartland Advisors: 2,994,313 Recent News Headlines: 2017-06-28 Interpace Diagnostics Announces National Contract With Aetna 2017-06-26 Interpace Diagnostics Announces Coverage Of Thyroid Test By Premera Blue Cross 2017-06-16 Interpace Diagnostics Announces Pricing Of $13.7 Million Underwritten Public Offering Of Common Stock And Common Warrants 2017-06-06 Interpace Diagnostics Announces Agreement With Einstein Medical Center Of Philadelphia 2017-05-25 Interpace Diagnostics Announces Launch Of Enhancement To Thyroid Testing Services 2017-05-16 Interpace Diagnostics Group's (IDXG) CEO Jack Stover on Q1 2017 Results - Earnings Call Transcript 2017-05-15 Interpace Diagnostics To Host Conference Call And Webcast To Discuss First Quarter 2017 Financial Results On Monday May 15, 2017 2017-05-10 Interpace Diagnostics Presents New Data on PancraGEN® at DDW 2017-04-20 Interpace Diagnostics Eliminates Long Term Secured Debt 2017-04-18 Interpace Diagnostics Announces Coverage Of ThyraMIR With UnitedHealthcare 2017-04-13 Interpace Diagnostics Announces Receipt of Letter From Nasdaq Confirming Compliance With Minimum Stockholders' Equity Requirement 2017-04-04 A Look at Interpace Diagnostics Financials, Drug Pipeline and Market Opportunity 2017-04-03 Interpace Diagnostics Announces European Patent Approval For Underlying Technology Of Its Thyramir Microrna Classifier
ILong
by StockGuild
VDRM Brings in Ivan Klarich" ViaDerma, Inc. (OTC PINK: VDRM), a specialty pharmaceutical company devoted to bringing new products to market, recently announced today that the Company has hired Mr. Ivan Klarich, who is an expert in managing the launching of "Go to Market" strategies for new product compliance. The Company wants to avoid the pitfalls often found in the launching a new product or product line. The Company wants to assure a solid strategy behind the launch for the labeling, marketing and distribution. The "Quality Control" plan will assure the product meets strict guidelines, starting with the manufacturer all the way through to the point of purchase. The Company plans to continue to hire several experts in the specialty pharmaceutical field as the Company rolls out an aggressive growth plan for 2017 and the years ahead." Very excited for this PR and what it means for the long run for VDRM. Anyone who has been following my posts knows I'm very long long on this company in 2017. I think we may see a 20% green day today, but even if we continue to go back down a bit I have no worries and will continuing buying more. VDRM long and strong! Millionaires will be made
OTC:VDRMLong
by Cryptocol